دورية أكاديمية

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

التفاصيل البيبلوغرافية
العنوان: Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis
المؤلفون: Zarębska-Michaluk, Dorota, Piekarska, Anna, Jaroszewicz, Jerzy, Klapaczyński, Jakub, Mazur, Włodzimierz, Krygier, Rafał, Belica-Wdowik, Teresa, Baka-Ćwierz, Barbara, Janczewska, Ewa, Pabjan, Paweł, Dobracka, Beata, Lorenc, Beata, Tudrujek-Zdunek, Magdalena, Tomasiewicz, Krzysztof, Sitko, Marek, Garlicki, Aleksander, Czauż-Andrzejuk, Agnieszka, Citko, Jolanta, Dybowska, Dorota, Halota, Waldemar, Pawłowska, Małgorzata, Laurans, Łukasz, Deroń, Zbigniew, Buczyńska, Iwona, Simon, Krzysztof, Białkowska, Jolanta, Tronina, Olga, Flisiak, Robert
المصدر: In Advances in Medical Sciences March 2020 65(1):12-17
قاعدة البيانات: ScienceDirect
الوصف
تدمد:18961126
DOI:10.1016/j.advms.2019.09.002